Laronde

Laronde is pioneering a platform that offers a completely novel way of modulating human biology. Endless RNA? (eRNA), is a uniquely engineered RNA that can be programmed to express diverse proteins inside the body. It is persistent, non-immunogenic, allows for repeat dosing, and offers flexibility in formulation and delivery. Laronde was founded in 2017 by Flagship Labs, the innovation foundry of Flagship Pioneering. The company is rapidly scaling to support the parallel development of multiple programs across many disease areas.

网站

https://laronde.bio

Laronde的外部链接

所属行业

生物技术

规模

11-50 人

总部

Cambridge，Massachusetts

类型

私人持股

创立

2017